A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This is a Phase 3 clinical trial in adult hypogonadal males with baseline serum testosterone
concentrations <300 ng/dL. The purpose of this study is to evaluate the safety and efficacy
of testosterone gel (2%) delivered using an applicator.